News & Events

Added to My Toolbox
Removed from My Toolbox
Added to My Toolbox
Removed from My Toolbox
Apr 10, 2018

Wearable Defibrillators Provide Temporary Fix for Heart Attack Patients

The device could be lifesaving for heart attack patients at high risk for sudden cardiac arrest.

Wearable defibrillators could be lifesaving for heart attack patients waiting for permanent devices, based on a study presented recently at the American College of Cardiology’s 67th Annual Scientific Session.

Wearable cardioverter defibrillators are devices that can be worn under the clothes to detect and correct abnormal heart rhythms. They’re typically used to prevent life-threatening heart events in patients waiting for a long-term treatment plan.

While wearable defibrillators can be used in patients with a variety of conditions, the recent study tested their benefits in heart attack survivors. All participants had recently suffered a heart attack and had reduced heart function (reduced left ventricular ejection fraction), putting them at increased risk for sudden cardiac arrest.

Sudden cardiac arrest occurs when the heart suddenly stops beating. It requires immediate medical attention and usually causes death if it’s not treated immediately.

The study included a total of 2,302 heart attack patients from four different countries. Two-thirds of participants were randomly assigned to receive a wearable defibrillator in the three months after their heart attack, in addition to standard therapy, such as medication and lifestyle changes. The rest of participants were assigned to standard therapy alone to serve as a control group.

When comparing outcomes after three months, researchers did not find a significant difference in the occurrence of sudden cardiac death between either group. However, there were significantly fewer strokes and deaths in patients with wearable devices than those standard therapy alone. Researchers also note that participants with wearable devices had significantly less shortness of breath, which is a common symptom of reduced heart function.

"This study found that the device was associated with fewer deaths among people recovering from a heart attack with low ejection fraction," explains lead author and the principal investigator of the study, Jeffrey Olgin, MD. "It's also the first therapy associated with a mortality benefit above and beyond standard medical therapy immediately after heart attack."

As a result, authors concluded that prescribing wearable defibrillators is reasonable to help protect high-risk patients after a heart attack. Wearable devices could be useful in the few months after a heart attack, while patients are waiting to be evaluated for implantable devices.

However, authors note that 19% of patients receiving the wearable defibrillator never actually wore the device. This number was higher than expected and highlights the need to improve adherence among patients prescribed wearable cardioverter defibrillators.

Questions for You to Consider

  • What is a wearable cardioverter defibrillator?

  • A wearable cardioverter defibrillator is a battery-powered device that can be worn underneath the clothes to detect and treat abnormal heart rhythms. The device uses electrical pulses or shocks to restore normal heart rhythm and prevent sudden cardiac death. It’s typically prescribed in patients at high risk for life-threatening arrhythmias (abnormal heart rhythms) while they await or consider more permanent treatment.

  • What is sudden cardiac death?

  • Sudden cardiac death can result from sudden cardiac arrest, when the heart suddenly and unexpectedly stops beating. Sudden cardiac arrest must be immediately addressed with CPR and medical attention to improve chances of survival.

Infographic: Sudden Cardiac Arrest


Driving Restriction Guidelines for Patients with Implantable Cardioverter Defibrillators

Find out which patients with ICDs shouldn’t drive within 2-4 months of their last shock.

Not All Heart Failure Patients Benefit Equally From ICDs

Implantable devices that help prevent sudden cardiac death don’t extend the lives of all patients with heart failure.

Women and Minorities Less Likely to Receive Counseling on ICDs for Heart Failure

Counseling on potentially life-saving heart failure treatment is lacking.

Lightweight Vest Protects Children with Abnormal Heart Rhythm

The FDA expands the use of a lifesaving vest to children at risk for sudden cardiac death.

Despite Common Fears, Exercise Safe for Patients with ICDs

Exercise is not only safe but improves heart health of patients with ICDs, says study.